MedTrace Logo

Gelesis Glycemic Index Study

NCT03124134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-02-15

No results posted yet for this study

Summary

A study to determine glucose and insulin responses to 50g and 100 g of carbohydrate with and without Gelesis200.

Conditions

Interventions

DEVICE

Gelesis200

Encapsulated hydrogel

OTHER

Water, only (placebo)

300 mL of water

Sponsors & Collaborators

  • inVentiv Health Clinical

    collaborator OTHER

  • Gelesis, Inc.

    lead INDUSTRY

Principal Investigators

  • Audet · inVentiv Health Clinique

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-18
Primary Completion
2017-05-18
Completion
2017-05-18

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03124134 on ClinicalTrials.gov